US 8795738
Use of arsenic for cancer therapy protection
granted A61KA61K33/36A61K45/06
Quick answer
US patent 8795738 (Use of arsenic for cancer therapy protection) held by The Board of Regents of the University of Texas System expires Mon Jul 31 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Aug 05 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 31 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K33/36, A61K45/06, A61P, A61P1/00